Organization Overview
Historical Acquisition Tree
Alternative names
erlotinib (tarceva) (2004 NDA)
bevacizumab (avastin) (4 trials)
capecitabine (xeloda) (1 trial)
carboplatin (paraplatin) (3 trials)
celecoxib (celebrex) (1 trial)
cisplatin (platinol) (5 trials)
everolimus (zortress) (3 trials)
Filgrastim (neupogen) (1 trial)
fludarabine (fludara) (1 trial)
fluorouracil (efudex) (3 trials)
fulvestrant (faslodex) (1 trial)
Adenocarcinoma (Phase 2)
Adenocarcinoma, Bronchiolo-Alveolar (Phase 2)
Adenocarcinoma of Lung (Phase 2)
Brain Neoplasms (Phase 2)
Breast Neoplasms (Phase 2)
Carcinoma (Phase 2)
Carcinoma, Hepatocellular (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Carcinoma, Ovarian Epithelial (Phase 2)
Carcinoma, Renal Cell (Phase 2)
Carcinoma, Small Cell (Phase 2)
Carcinoma, Squamous Cell (Phase 2)
Colorectal Neoplasms (Phase 2)
Crohn Disease (Phase 2)
Ependymoma (Phase 2)
Esophageal Neoplasms (Phase 2)
Exanthema (Phase 4)
Glioblastoma (Phase 2)
Glioma (Phase 2)
Gliosarcoma (Phase 2)
Head and Neck Neoplasms (Phase 2)
Leukemia (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Lymphoid (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Leukemia, Myelomonocytic, Acute (Phase 2)
Liver Neoplasms (Phase 2)
Lung Neoplasms (Phase 3)
Melanoma (Phase 2)
Neoplasm Metastasis (Phase 2)
Neoplasms (Phase 1)
Neoplasms, Squamous Cell (Phase 2)
Ovarian Neoplasms (Phase 2)
Pancreatic Neoplasms (Phase 3)
Pharyngeal Neoplasms (Phase 1)
Polycythemia (Phase 2)
Polycythemia Vera (Phase 2)
Prostatic Neoplasms (Phase 2)
Psoriasis (Phase 2)
Skin Neoplasms (Phase 2)
Small Cell Lung Carcinoma (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 2)